Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) Net Margin (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Net Margin readings, the most recent being 26.54% for Q4 2025.

  • On a quarterly basis, Net Margin rose 4426.0% to 26.54% in Q4 2025 year-over-year; TTM through Dec 2025 was 28.18%, a 2261.0% increase, with the full-year FY2025 number at 32.47%, up 1676.0% from a year prior.
  • Net Margin hit 26.54% in Q4 2025 for SBC Medical Group Holdings, down from 33.41% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 45.41% in Q1 2025 to a low of 17.72% in Q4 2024.
  • Median Net Margin over the past 3 years was 21.04% (2023), compared with a mean of 17.17%.
  • Biggest five-year swings in Net Margin: crashed -4275bps in 2024 and later surged 4594bps in 2025.
  • SBC Medical Group Holdings' Net Margin stood at 25.04% in 2023, then plummeted by -171bps to 17.72% in 2024, then soared by 250bps to 26.54% in 2025.
  • The last three reported values for Net Margin were 26.54% (Q4 2025), 33.41% (Q3 2025), and 5.63% (Q2 2025) per Business Quant data.